Nanoviricides (NNVC) Retained Earnings (2011 - 2026)

Nanoviricides has disclosed Retained Earnings across 16 years of filings, most recently posting $164.0 million for Q1 2026.

• In Q1 2026, Retained Earnings rose 5.41% year-over-year to $164.0 million; the TTM figure through Mar 2026 stood at $164.0 million (up 5.41% YoY), while the FY2025 annual figure was $156.4 million, up 3.66% from the prior year.
• Retained Earnings came in at $164.0 million for Q1 2026 at Nanoviricides, roughly flat from $163.9 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $164.0 million in Q1 2026 to a low of $145.5 million in Q1 2022.
• Average Retained Earnings over 5 years is $151.3 million, with a median of $147.7 million recorded in 2024.
• Year-over-year, Retained Earnings rose 0.18% in 2023 and rose 5.81% in 2025.
• Over 5 years, Retained Earnings stood at $145.7 million in 2022, then climbed by 1.34% to $147.6 million in 2023, then gained by 4.95% to $154.9 million in 2024, then climbed by 5.81% to $163.9 million in 2025, then advanced by 0.04% to $164.0 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $164.0 million in Q1 2026, $163.9 million in Q4 2025, and $157.8 million in Q3 2025.